Skip to main content
. 2017 Aug 2;8(40):68681–68695. doi: 10.18632/oncotarget.19826

Figure 1. HDM-immunotherapy attenuates HDM-induced airway inflammation.

Figure 1

(A) HDM-specific immunotherapy protocol for HDM- inducing asthmatic mice (n = 8 mice for each group). (B) Total number of inflammatory cells as well as eosinophils, neutrophils and lymphocytes in the BAL of mice were determined by differential cell analysis. (C) Lung tissues were stained using H&E (original magnification, ×200). (D) The inflammatory cell infiltration index was determined in the lungs in (C). One-way ANOVA for group comparisons. Significant differences in the mean values were defined as p < 0.05. PBS mice indicated PBS control mice. SIT mice indicated HDM-immunotherapy mice. HDM mice indicated HDM-sensitized and challenged mice.